Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Adipocytes, White | 3 | 2018 | 89 | 0.870 |
Why?
|
Adipocytes, Brown | 3 | 2020 | 144 | 0.870 |
Why?
|
Receptor, Insulin | 5 | 2023 | 846 | 0.690 |
Why?
|
Metabolome | 3 | 2021 | 895 | 0.620 |
Why?
|
Gastric Bypass | 3 | 2021 | 812 | 0.570 |
Why?
|
Metabolic Networks and Pathways | 3 | 2019 | 783 | 0.560 |
Why?
|
Receptor, IGF Type 1 | 4 | 2023 | 390 | 0.500 |
Why?
|
Hypoglycemia | 4 | 2023 | 861 | 0.490 |
Why?
|
Energy Metabolism | 5 | 2020 | 2899 | 0.470 |
Why?
|
Neurospora crassa | 1 | 2013 | 27 | 0.470 |
Why?
|
Insulin-Secreting Cells | 4 | 2023 | 891 | 0.440 |
Why?
|
Proteome | 2 | 2021 | 1799 | 0.420 |
Why?
|
Genome, Fungal | 1 | 2013 | 204 | 0.420 |
Why?
|
Genome, Human | 2 | 2017 | 4420 | 0.410 |
Why?
|
Insulin | 14 | 2023 | 6580 | 0.380 |
Why?
|
Liver | 7 | 2023 | 7474 | 0.380 |
Why?
|
Lipid Metabolism | 7 | 2020 | 1889 | 0.380 |
Why?
|
Glucose | 8 | 2023 | 4397 | 0.370 |
Why?
|
Gene Expression Profiling | 12 | 2021 | 9438 | 0.350 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2021 | 11725 | 0.350 |
Why?
|
Heparitin Sulfate | 1 | 2010 | 225 | 0.350 |
Why?
|
Glycomics | 1 | 2010 | 121 | 0.340 |
Why?
|
Fibroblast Growth Factors | 4 | 2019 | 879 | 0.340 |
Why?
|
Gene Expression Regulation | 10 | 2023 | 12072 | 0.320 |
Why?
|
Obesity | 7 | 2023 | 12745 | 0.300 |
Why?
|
Betaine | 2 | 2018 | 87 | 0.290 |
Why?
|
Gene Regulatory Networks | 4 | 2023 | 1708 | 0.290 |
Why?
|
Insulin Resistance | 7 | 2022 | 3864 | 0.280 |
Why?
|
Islets of Langerhans | 2 | 2023 | 1352 | 0.270 |
Why?
|
Astrocytoma | 1 | 2009 | 790 | 0.250 |
Why?
|
Insulin Antagonists | 1 | 2023 | 20 | 0.230 |
Why?
|
Models, Genetic | 2 | 2023 | 3494 | 0.230 |
Why?
|
Mass Spectrometry | 2 | 2010 | 2203 | 0.230 |
Why?
|
Models, Biological | 6 | 2020 | 9583 | 0.230 |
Why?
|
Signal Transduction | 10 | 2023 | 23403 | 0.220 |
Why?
|
Insulinoma | 1 | 2023 | 124 | 0.220 |
Why?
|
Bariatrics | 1 | 2023 | 34 | 0.220 |
Why?
|
Blood Glucose | 7 | 2023 | 6256 | 0.210 |
Why?
|
Dipeptidases | 1 | 2021 | 38 | 0.210 |
Why?
|
rho GTP-Binding Proteins | 2 | 2021 | 293 | 0.210 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 76 | 0.200 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2021 | 123 | 0.200 |
Why?
|
TNF Receptor-Associated Factor 3 | 1 | 2021 | 40 | 0.200 |
Why?
|
Software | 2 | 2017 | 4443 | 0.190 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2020 | 9 | 0.190 |
Why?
|
Planarians | 1 | 2021 | 52 | 0.190 |
Why?
|
Apoptosis | 4 | 2023 | 9727 | 0.180 |
Why?
|
Rod Opsins | 1 | 2020 | 111 | 0.170 |
Why?
|
Adipokines | 2 | 2019 | 319 | 0.170 |
Why?
|
Paternal Exposure | 1 | 2019 | 89 | 0.170 |
Why?
|
Human Growth Hormone | 2 | 2021 | 683 | 0.170 |
Why?
|
Cell Line, Transformed | 2 | 2017 | 898 | 0.170 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2019 | 85 | 0.170 |
Why?
|
Thermogenesis | 3 | 2020 | 435 | 0.160 |
Why?
|
Transforming Growth Factor beta2 | 1 | 2019 | 75 | 0.160 |
Why?
|
Animals | 34 | 2023 | 168757 | 0.160 |
Why?
|
4-Aminobutyrate Transaminase | 1 | 2017 | 13 | 0.160 |
Why?
|
Fasting | 2 | 2021 | 1593 | 0.160 |
Why?
|
Cell Division | 2 | 2023 | 4568 | 0.160 |
Why?
|
Intermittent Claudication | 1 | 2020 | 309 | 0.160 |
Why?
|
Adipose Tissue | 3 | 2019 | 3279 | 0.150 |
Why?
|
Enzymes | 1 | 2019 | 266 | 0.150 |
Why?
|
Pyruvate Kinase | 1 | 2019 | 189 | 0.150 |
Why?
|
Palmitic Acid | 1 | 2017 | 154 | 0.150 |
Why?
|
Escherichia coli Infections | 1 | 2021 | 532 | 0.150 |
Why?
|
Ammonia | 1 | 2017 | 239 | 0.140 |
Why?
|
Gluconeogenesis | 1 | 2017 | 183 | 0.140 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2019 | 2408 | 0.140 |
Why?
|
Muscle, Skeletal | 3 | 2020 | 4931 | 0.140 |
Why?
|
Diabetes Mellitus, Type 1 | 2 | 2023 | 3336 | 0.140 |
Why?
|
Mice | 22 | 2023 | 81183 | 0.140 |
Why?
|
Organ Specificity | 3 | 2017 | 2008 | 0.140 |
Why?
|
Adipogenesis | 1 | 2018 | 359 | 0.140 |
Why?
|
Metabolomics | 3 | 2020 | 1484 | 0.130 |
Why?
|
Pancreatic Neoplasms | 2 | 2023 | 5256 | 0.130 |
Why?
|
Satellite Cells, Skeletal Muscle | 1 | 2016 | 124 | 0.130 |
Why?
|
Muscular Atrophy | 1 | 2018 | 349 | 0.130 |
Why?
|
Urea | 1 | 2017 | 450 | 0.130 |
Why?
|
Paracrine Communication | 1 | 2017 | 277 | 0.130 |
Why?
|
Physical Conditioning, Animal | 1 | 2019 | 362 | 0.130 |
Why?
|
Umbilical Cord | 1 | 2016 | 180 | 0.130 |
Why?
|
Leiomyoma | 2 | 2012 | 730 | 0.130 |
Why?
|
Unfolded Protein Response | 1 | 2017 | 233 | 0.130 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2017 | 2916 | 0.130 |
Why?
|
Hepatocytes | 1 | 2021 | 1211 | 0.130 |
Why?
|
Hyperglycemia | 1 | 2023 | 1373 | 0.120 |
Why?
|
Glutamine | 1 | 2017 | 578 | 0.120 |
Why?
|
Regeneration | 2 | 2021 | 1485 | 0.120 |
Why?
|
Phosphorylation | 6 | 2023 | 8436 | 0.120 |
Why?
|
Glioblastoma | 1 | 2009 | 3481 | 0.120 |
Why?
|
Body Mass Index | 3 | 2021 | 12720 | 0.120 |
Why?
|
Th1 Cells | 1 | 2019 | 1057 | 0.120 |
Why?
|
Mycobacterium tuberculosis | 2 | 2015 | 1832 | 0.110 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2023 | 2455 | 0.110 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2016 | 555 | 0.110 |
Why?
|
MicroRNAs | 3 | 2017 | 3752 | 0.110 |
Why?
|
Phosphoproteins | 2 | 2023 | 2440 | 0.110 |
Why?
|
Prediabetic State | 1 | 2018 | 499 | 0.110 |
Why?
|
Stress, Physiological | 2 | 2017 | 1403 | 0.110 |
Why?
|
Longevity | 1 | 2020 | 1070 | 0.110 |
Why?
|
Th17 Cells | 1 | 2019 | 766 | 0.110 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2018 | 1116 | 0.110 |
Why?
|
Hymecromone | 1 | 2011 | 9 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2019 | 984 | 0.100 |
Why?
|
gamma-Aminobutyric Acid | 1 | 2017 | 1121 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1907 | 0.100 |
Why?
|
Germ Cells | 1 | 2015 | 631 | 0.100 |
Why?
|
Uterine Neoplasms | 2 | 2012 | 1513 | 0.100 |
Why?
|
Forkhead Transcription Factors | 1 | 2018 | 1613 | 0.100 |
Why?
|
Rats | 4 | 2023 | 24260 | 0.100 |
Why?
|
Oxygen Consumption | 1 | 2017 | 1869 | 0.100 |
Why?
|
Sex Characteristics | 1 | 2021 | 2585 | 0.100 |
Why?
|
Humans | 46 | 2023 | 744343 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.100 |
Why?
|
Fatty Acids | 1 | 2019 | 1809 | 0.100 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 2010 | 124 | 0.090 |
Why?
|
Antigens, CD | 1 | 2021 | 4026 | 0.090 |
Why?
|
Gene Expression | 4 | 2017 | 7799 | 0.090 |
Why?
|
Insulin Receptor Substrate Proteins | 2 | 2023 | 563 | 0.090 |
Why?
|
Pancreas | 1 | 2017 | 1686 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2849 | 0.090 |
Why?
|
Angiogenesis Inhibitors | 2 | 2010 | 2038 | 0.090 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1188 | 0.090 |
Why?
|
Bariatric Surgery | 1 | 2019 | 952 | 0.090 |
Why?
|
Homeostasis | 2 | 2017 | 3340 | 0.090 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2010 | 407 | 0.090 |
Why?
|
Blood Glucose Self-Monitoring | 2 | 2023 | 434 | 0.080 |
Why?
|
Adipose Tissue, Brown | 3 | 2020 | 757 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2021 | 15295 | 0.080 |
Why?
|
Enterocytes | 1 | 2010 | 225 | 0.080 |
Why?
|
Chromosomes, Human, Pair 7 | 1 | 2009 | 322 | 0.080 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2015 | 852 | 0.080 |
Why?
|
Leucine | 2 | 2023 | 561 | 0.080 |
Why?
|
Escherichia coli | 1 | 2021 | 4217 | 0.080 |
Why?
|
Mothers | 2 | 2016 | 2165 | 0.080 |
Why?
|
Fetal Blood | 1 | 2015 | 1318 | 0.080 |
Why?
|
Short Bowel Syndrome | 1 | 2012 | 345 | 0.080 |
Why?
|
Dietary Fats | 1 | 2016 | 2017 | 0.080 |
Why?
|
Obesity, Morbid | 1 | 2019 | 1213 | 0.080 |
Why?
|
Sarcoma | 2 | 2010 | 1897 | 0.080 |
Why?
|
Genetic Heterogeneity | 1 | 2012 | 733 | 0.080 |
Why?
|
Glycosaminoglycans | 1 | 2011 | 624 | 0.080 |
Why?
|
Jejunum | 1 | 2010 | 480 | 0.080 |
Why?
|
Carrier Proteins | 1 | 2021 | 5021 | 0.080 |
Why?
|
Brain Neoplasms | 1 | 2009 | 8863 | 0.080 |
Why?
|
Area Under Curve | 1 | 2012 | 1654 | 0.080 |
Why?
|
Chromosome Aberrations | 2 | 2012 | 1813 | 0.080 |
Why?
|
NF-kappa B | 1 | 2016 | 2499 | 0.080 |
Why?
|
Hyaluronic Acid | 1 | 2011 | 491 | 0.080 |
Why?
|
Mice, Knockout | 5 | 2022 | 14557 | 0.070 |
Why?
|
RNA, Messenger | 6 | 2023 | 13033 | 0.070 |
Why?
|
Myocytes, Smooth Muscle | 1 | 2011 | 687 | 0.070 |
Why?
|
Chromatography, Liquid | 1 | 2010 | 976 | 0.070 |
Why?
|
Cell Proliferation | 7 | 2022 | 10481 | 0.070 |
Why?
|
Caenorhabditis elegans | 1 | 2015 | 1419 | 0.070 |
Why?
|
Mice, Inbred C57BL | 6 | 2020 | 21827 | 0.070 |
Why?
|
Crohn Disease | 1 | 2019 | 2303 | 0.070 |
Why?
|
Genes | 1 | 2010 | 1893 | 0.070 |
Why?
|
Intestine, Small | 1 | 2012 | 1241 | 0.070 |
Why?
|
DNA Methylation | 1 | 2019 | 4286 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 627 | 0.070 |
Why?
|
Male | 27 | 2023 | 350118 | 0.060 |
Why?
|
Breast Neoplasms | 1 | 2012 | 20822 | 0.060 |
Why?
|
Data Mining | 1 | 2010 | 537 | 0.060 |
Why?
|
Chromosome Deletion | 1 | 2009 | 1401 | 0.060 |
Why?
|
Cattle | 1 | 2010 | 3922 | 0.060 |
Why?
|
ROC Curve | 1 | 2012 | 3527 | 0.060 |
Why?
|
RNA Polymerase II | 1 | 2008 | 551 | 0.060 |
Why?
|
Models, Cardiovascular | 1 | 2009 | 996 | 0.060 |
Why?
|
Female | 23 | 2023 | 380194 | 0.060 |
Why?
|
Transcription, Genetic | 3 | 2017 | 7722 | 0.060 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2023 | 2015 | 0.060 |
Why?
|
Genetic Engineering | 1 | 2010 | 951 | 0.060 |
Why?
|
Fructokinases | 1 | 2023 | 6 | 0.060 |
Why?
|
Transcription Factors | 4 | 2017 | 12208 | 0.060 |
Why?
|
Aorta | 1 | 2011 | 2061 | 0.060 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2009 | 2649 | 0.060 |
Why?
|
Muscle Proteins | 2 | 2018 | 1159 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2013 | 2942 | 0.060 |
Why?
|
DNA-Binding Proteins | 3 | 2015 | 9648 | 0.060 |
Why?
|
Pyrroles | 1 | 2009 | 1146 | 0.050 |
Why?
|
Myositis | 1 | 2005 | 251 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2021 | 2503 | 0.050 |
Why?
|
Terminology as Topic | 1 | 2010 | 1547 | 0.050 |
Why?
|
E2F1 Transcription Factor | 1 | 2022 | 190 | 0.050 |
Why?
|
Cell Line | 4 | 2021 | 15997 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2016 | 2861 | 0.050 |
Why?
|
Case-Control Studies | 5 | 2020 | 21746 | 0.050 |
Why?
|
Genes, Reporter | 2 | 2017 | 1547 | 0.050 |
Why?
|
Carcinoma | 1 | 2013 | 2375 | 0.050 |
Why?
|
Lipogenesis | 1 | 2023 | 212 | 0.050 |
Why?
|
Meningioma | 1 | 2010 | 1209 | 0.050 |
Why?
|
Fatty Liver | 2 | 2019 | 727 | 0.050 |
Why?
|
Inflammation | 6 | 2021 | 10638 | 0.050 |
Why?
|
Mitochondria | 3 | 2020 | 3520 | 0.050 |
Why?
|
Algorithms | 3 | 2013 | 13881 | 0.050 |
Why?
|
Fructose | 1 | 2023 | 288 | 0.050 |
Why?
|
Meningeal Neoplasms | 1 | 2010 | 1241 | 0.050 |
Why?
|
Indoles | 1 | 2009 | 1839 | 0.050 |
Why?
|
Soft Tissue Neoplasms | 1 | 2010 | 1363 | 0.050 |
Why?
|
Calcinosis | 1 | 2009 | 1499 | 0.050 |
Why?
|
Predictive Value of Tests | 3 | 2012 | 15076 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2020 | 1222 | 0.050 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2013 | 2245 | 0.050 |
Why?
|
Phosphatidylinositol Phosphates | 1 | 2021 | 209 | 0.050 |
Why?
|
Data Interpretation, Statistical | 2 | 2007 | 2716 | 0.040 |
Why?
|
Postprandial Period | 1 | 2021 | 292 | 0.040 |
Why?
|
Random Allocation | 2 | 2017 | 2429 | 0.040 |
Why?
|
RNA-Binding Proteins | 1 | 2008 | 1903 | 0.040 |
Why?
|
Birth Weight | 2 | 2019 | 2069 | 0.040 |
Why?
|
Gastrointestinal Hormones | 1 | 2019 | 97 | 0.040 |
Why?
|
Saccharomyces cerevisiae Proteins | 1 | 2008 | 1888 | 0.040 |
Why?
|
Computer Simulation | 1 | 2012 | 6196 | 0.040 |
Why?
|
Karyotyping | 2 | 2012 | 1243 | 0.040 |
Why?
|
Diglycerides | 1 | 2019 | 176 | 0.040 |
Why?
|
Circadian Rhythm | 1 | 2010 | 2624 | 0.040 |
Why?
|
Bacteroides | 1 | 2019 | 161 | 0.040 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2023 | 2938 | 0.040 |
Why?
|
Artifacts | 1 | 2007 | 1904 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2009 | 3508 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7181 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2012 | 3920 | 0.040 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 498 | 0.040 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2017 | 38 | 0.040 |
Why?
|
WT1 Proteins | 1 | 2018 | 178 | 0.040 |
Why?
|
Glucose-6-Phosphatase | 1 | 2017 | 73 | 0.040 |
Why?
|
Skin Absorption | 2 | 1975 | 94 | 0.040 |
Why?
|
Ketones | 1 | 2019 | 188 | 0.040 |
Why?
|
Hemolytic Plaque Technique | 1 | 2017 | 66 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2018 | 4751 | 0.040 |
Why?
|
Computational Biology | 1 | 2010 | 3521 | 0.040 |
Why?
|
Gene Knock-In Techniques | 1 | 2019 | 418 | 0.040 |
Why?
|
Saccharomyces cerevisiae | 1 | 2008 | 2752 | 0.040 |
Why?
|
Middle Aged | 12 | 2021 | 213383 | 0.040 |
Why?
|
Sodium Salicylate | 1 | 2016 | 19 | 0.040 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2019 | 340 | 0.040 |
Why?
|
Feces | 3 | 2019 | 1401 | 0.040 |
Why?
|
Up-Regulation | 2 | 2019 | 4217 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2018 | 3462 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2009 | 8428 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2017 | 393 | 0.040 |
Why?
|
Sequence Analysis, DNA | 2 | 2021 | 4803 | 0.040 |
Why?
|
Population Surveillance | 1 | 2007 | 2616 | 0.030 |
Why?
|
Kidney Glomerulus | 1 | 2019 | 697 | 0.030 |
Why?
|
Binding Sites | 2 | 2017 | 6114 | 0.030 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2021 | 745 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2021 | 77449 | 0.030 |
Why?
|
Tumor Burden | 2 | 2013 | 1915 | 0.030 |
Why?
|
Adult | 12 | 2021 | 214055 | 0.030 |
Why?
|
Proteomics | 2 | 2019 | 3638 | 0.030 |
Why?
|
Ligands | 1 | 2023 | 3282 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2020 | 1213 | 0.030 |
Why?
|
Receptors, Endothelin | 1 | 2015 | 58 | 0.030 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2019 | 611 | 0.030 |
Why?
|
Receptor, Endothelin B | 1 | 2015 | 41 | 0.030 |
Why?
|
Phenylalanine | 1 | 2017 | 365 | 0.030 |
Why?
|
Autopsy | 1 | 2019 | 1020 | 0.030 |
Why?
|
Phagocytosis | 1 | 2021 | 1539 | 0.030 |
Why?
|
Aged | 9 | 2020 | 163280 | 0.030 |
Why?
|
DNA, Complementary | 1 | 2018 | 2050 | 0.030 |
Why?
|
Antibodies | 1 | 2023 | 2460 | 0.030 |
Why?
|
Ribonuclease III | 1 | 2017 | 275 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 513 | 0.030 |
Why?
|
Genotype | 3 | 2019 | 12951 | 0.030 |
Why?
|
Muscle Development | 1 | 2016 | 271 | 0.030 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2010 | 4034 | 0.030 |
Why?
|
Proteins | 1 | 2010 | 6103 | 0.030 |
Why?
|
Dietary Supplements | 2 | 2018 | 3297 | 0.030 |
Why?
|
Blood Proteins | 1 | 2019 | 1124 | 0.030 |
Why?
|
Adipocytes | 1 | 2021 | 1184 | 0.030 |
Why?
|
Adipose Tissue, White | 1 | 2017 | 351 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2017 | 5974 | 0.030 |
Why?
|
Disease Progression | 3 | 2019 | 13284 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1676 | 0.030 |
Why?
|
Glucose Tolerance Test | 1 | 2017 | 1150 | 0.030 |
Why?
|
Lysosomes | 1 | 2018 | 893 | 0.030 |
Why?
|
Light | 1 | 2020 | 1374 | 0.030 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2017 | 1723 | 0.030 |
Why?
|
Atherosclerosis | 1 | 2009 | 3445 | 0.030 |
Why?
|
Brain Death | 1 | 2017 | 348 | 0.030 |
Why?
|
Nuclear Proteins | 1 | 2008 | 5853 | 0.030 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2006 | 2104 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2016 | 346 | 0.030 |
Why?
|
Immune System | 1 | 2019 | 805 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12261 | 0.030 |
Why?
|
Microfilament Proteins | 1 | 2018 | 1152 | 0.030 |
Why?
|
Walking | 1 | 2020 | 1180 | 0.030 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2016 | 378 | 0.030 |
Why?
|
Polymorphism, Genetic | 2 | 2019 | 4328 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 827 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2010 | 6364 | 0.030 |
Why?
|
Oxygen | 2 | 2015 | 4189 | 0.030 |
Why?
|
Amino Acids | 1 | 2018 | 1736 | 0.030 |
Why?
|
Alleles | 2 | 2019 | 6933 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2021 | 2109 | 0.030 |
Why?
|
Exosomes | 1 | 2017 | 417 | 0.030 |
Why?
|
Species Specificity | 1 | 2016 | 2478 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2017 | 1791 | 0.030 |
Why?
|
Time Factors | 3 | 2010 | 40075 | 0.030 |
Why?
|
Bayes Theorem | 2 | 2010 | 2309 | 0.030 |
Why?
|
Clone Cells | 1 | 2015 | 1692 | 0.030 |
Why?
|
Prognosis | 1 | 2012 | 29063 | 0.030 |
Why?
|
Glucose Intolerance | 1 | 2016 | 577 | 0.030 |
Why?
|
HMGA2 Protein | 1 | 2012 | 123 | 0.020 |
Why?
|
Sirolimus | 1 | 2019 | 1564 | 0.020 |
Why?
|
Cyclic AMP | 1 | 1975 | 1472 | 0.020 |
Why?
|
Dibenzoxazepines | 1 | 1971 | 8 | 0.020 |
Why?
|
Peptides | 1 | 2023 | 4409 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2017 | 2088 | 0.020 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2015 | 581 | 0.020 |
Why?
|
Mass Screening | 1 | 2007 | 5255 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2019 | 2170 | 0.020 |
Why?
|
Pregnancy | 3 | 2019 | 29144 | 0.020 |
Why?
|
Infant | 3 | 2019 | 35136 | 0.020 |
Why?
|
Myometrium | 1 | 2012 | 181 | 0.020 |
Why?
|
Bacterial Proteins | 2 | 2015 | 3848 | 0.020 |
Why?
|
Autophagy | 1 | 2018 | 1300 | 0.020 |
Why?
|
Fetal Development | 1 | 2016 | 767 | 0.020 |
Why?
|
Cell Enlargement | 1 | 2010 | 61 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2013 | 551 | 0.020 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2013 | 893 | 0.020 |
Why?
|
Ion Channels | 1 | 2015 | 1056 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 17446 | 0.020 |
Why?
|
Cell Movement | 2 | 2013 | 5217 | 0.020 |
Why?
|
Intestinal Mucosa | 2 | 2012 | 3036 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 2 | 2012 | 8301 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 6487 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 480 | 0.020 |
Why?
|
Photoperiod | 1 | 2010 | 136 | 0.020 |
Why?
|
Inflammation Mediators | 1 | 2018 | 1889 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 489 | 0.020 |
Why?
|
Adiposity | 1 | 2019 | 1807 | 0.020 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1736 | 0.020 |
Why?
|
STAT3 Transcription Factor | 1 | 2013 | 873 | 0.020 |
Why?
|
G1 Phase | 1 | 2010 | 415 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2010 | 462 | 0.020 |
Why?
|
Mitochondrial Proteins | 1 | 2015 | 996 | 0.020 |
Why?
|
Cohort Studies | 3 | 2019 | 40561 | 0.020 |
Why?
|
Poly A | 1 | 2008 | 185 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor beta | 1 | 2009 | 188 | 0.020 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2008 | 98 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3719 | 0.020 |
Why?
|
Protein Kinases | 1 | 2015 | 1640 | 0.020 |
Why?
|
Casein Kinase II | 1 | 2008 | 128 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2009 | 496 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2010 | 684 | 0.020 |
Why?
|
Cyclins | 1 | 2010 | 603 | 0.020 |
Why?
|
Toll-Like Receptor 4 | 1 | 2011 | 565 | 0.020 |
Why?
|
Aging | 2 | 2017 | 8664 | 0.020 |
Why?
|
Cyclin-Dependent Kinase 6 | 1 | 2010 | 322 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2013 | 19905 | 0.020 |
Why?
|
Hallucinogens | 1 | 1971 | 180 | 0.020 |
Why?
|
Lipids | 1 | 2019 | 3305 | 0.020 |
Why?
|
Gene Deletion | 1 | 2015 | 2751 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 3023 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2019 | 25625 | 0.020 |
Why?
|
Binding, Competitive | 1 | 2008 | 1157 | 0.020 |
Why?
|
Systems Biology | 1 | 2010 | 469 | 0.020 |
Why?
|
Gene Silencing | 1 | 2013 | 1538 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2019 | 5097 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2009 | 730 | 0.020 |
Why?
|
Mosaicism | 1 | 2009 | 441 | 0.020 |
Why?
|
North Carolina | 1 | 2007 | 315 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2282 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57776 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2013 | 1312 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 546 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2019 | 3647 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9687 | 0.020 |
Why?
|
Malawi | 1 | 2007 | 282 | 0.020 |
Why?
|
Microvessels | 1 | 2010 | 544 | 0.020 |
Why?
|
Muscle, Smooth | 1 | 2010 | 934 | 0.020 |
Why?
|
Catalytic Domain | 1 | 2008 | 698 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2009 | 13695 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2010 | 13102 | 0.020 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2008 | 502 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1252 | 0.020 |
Why?
|
Classification | 1 | 2006 | 129 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3617 | 0.020 |
Why?
|
HLA-C Antigens | 1 | 2005 | 147 | 0.020 |
Why?
|
Cell Membrane | 1 | 2015 | 3748 | 0.020 |
Why?
|
HLA-DQ Antigens | 1 | 2005 | 210 | 0.020 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2017 | 2214 | 0.020 |
Why?
|
Uterus | 1 | 2009 | 711 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2013 | 3557 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2012 | 1434 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2208 | 0.020 |
Why?
|
Biotransformation | 3 | 1975 | 168 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2012 | 2715 | 0.020 |
Why?
|
Weight Gain | 1 | 2015 | 2292 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2018 | 12026 | 0.020 |
Why?
|
HLA-B Antigens | 1 | 2005 | 353 | 0.010 |
Why?
|
Blotting, Western | 1 | 2012 | 5179 | 0.010 |
Why?
|
Biometry | 1 | 2007 | 558 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2010 | 2879 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2005 | 645 | 0.010 |
Why?
|
Cytokines | 1 | 2018 | 7322 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5867 | 0.010 |
Why?
|
Kidney | 1 | 2019 | 7186 | 0.010 |
Why?
|
Glycoproteins | 1 | 2011 | 2263 | 0.010 |
Why?
|
Risk Factors | 4 | 2015 | 72290 | 0.010 |
Why?
|
Transfection | 1 | 2010 | 5892 | 0.010 |
Why?
|
Stem Cells | 1 | 2015 | 3567 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2017 | 4253 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18029 | 0.010 |
Why?
|
Mutation | 2 | 2020 | 29786 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2008 | 3846 | 0.010 |
Why?
|
HIV Infections | 1 | 2007 | 16718 | 0.010 |
Why?
|
Tuberculosis | 1 | 2013 | 1912 | 0.010 |
Why?
|
Adolescent | 2 | 2019 | 85781 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2009 | 6171 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19229 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2010 | 2728 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2005 | 1782 | 0.010 |
Why?
|
Dogs | 2 | 1975 | 3912 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11483 | 0.010 |
Why?
|
Genomics | 1 | 2013 | 5720 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2009 | 8642 | 0.010 |
Why?
|
Child, Preschool | 1 | 2019 | 41006 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9734 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2013 | 16689 | 0.010 |
Why?
|
DNA | 1 | 2010 | 7301 | 0.010 |
Why?
|
Half-Life | 1 | 1975 | 661 | 0.010 |
Why?
|
Administration, Topical | 1 | 1975 | 690 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2010 | 9239 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2007 | 14722 | 0.010 |
Why?
|
Child | 1 | 2019 | 77709 | 0.010 |
Why?
|
Glucuronates | 1 | 1971 | 40 | 0.010 |
Why?
|
Comorbidity | 1 | 2006 | 10388 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1971 | 223 | 0.010 |
Why?
|
Sulfatases | 1 | 1971 | 45 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2010 | 15519 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 56430 | 0.010 |
Why?
|
Adenosine | 1 | 1975 | 825 | 0.010 |
Why?
|
Prevalence | 1 | 2007 | 15226 | 0.010 |
Why?
|
Genetic Variation | 1 | 2005 | 6544 | 0.010 |
Why?
|
Bile | 1 | 1971 | 299 | 0.010 |
Why?
|
Dimethyl Sulfoxide | 1 | 1971 | 249 | 0.010 |
Why?
|
Carbon Radioisotopes | 1 | 1971 | 577 | 0.010 |
Why?
|
Glucuronidase | 1 | 1971 | 207 | 0.010 |
Why?
|
Dermatologic Agents | 1 | 1971 | 278 | 0.000 |
Why?
|
Brain Chemistry | 1 | 1971 | 981 | 0.000 |
Why?
|
Eye | 1 | 1971 | 729 | 0.000 |
Why?
|
Hospitalization | 1 | 2006 | 10262 | 0.000 |
Why?
|
Ethanol | 1 | 1971 | 1342 | 0.000 |
Why?
|
Risk Assessment | 1 | 2005 | 23338 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2010 | 63114 | 0.000 |
Why?
|
Kinetics | 1 | 1971 | 6473 | 0.000 |
Why?
|
Skin | 1 | 1975 | 4364 | 0.000 |
Why?
|
Piperazines | 1 | 1971 | 2488 | 0.000 |
Why?
|
Lung | 1 | 1971 | 9856 | 0.000 |
Why?
|
Chromatography, Gas | 1 | 1971 | 156 | 0.000 |
Why?
|
Spectrophotometry | 1 | 1971 | 313 | 0.000 |
Why?
|
Air | 1 | 1971 | 182 | 0.000 |
Why?
|
Sulfides | 1 | 1971 | 165 | 0.000 |
Why?
|
Carbon Isotopes | 1 | 1971 | 467 | 0.000 |
Why?
|
Gels | 1 | 1971 | 427 | 0.000 |
Why?
|
Sulfones | 1 | 1971 | 437 | 0.000 |
Why?
|
Swine | 1 | 1971 | 5917 | 0.000 |
Why?
|